Preclinical Characterization of ADX-097, a Tissue Targeted Complement Therapeutic for Kidney Diseases
Time: 2:00 pm
day: Conference Day One Track A PM
Details:
- Characterizing the role of local and systemic inhibition in treating kidney tissue injury
- Translational considerations around moving a drug from preclinical to clinical
- Thoughts around biomarkers and their use within precision medicine
